Toshinari Yamashita

23PUBLICATIONS
138CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.

Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem

|Mar 21, 2025
Is adjuvant olaparib standard of care in all high-risk HER2-negative early breast cancer presenting gBRCA1/2 mutations?

Pierre Foidart, Guy Jerusalem

|Dec 09, 2024
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.

Nadia Harbeck, Eva Ciruelos, Guy Jerusalem

|Oct 10, 2024
Network Analyses Applied to the Dimensions of Cancer-Related Fatigue in Women With Breast Cancer.

Louise Baussard, Marie Ernst, Anh Diep

|Sep 13, 2024
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.

Nadia Harbeck, Eva Ciruelos, Guy Jerusalem

|Oct 27, 2023
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer.

Matthew P Goetz, Erika P Hamilton, Mario Campone

Pageof 4

Frequent Collaborators

4 joint publications

Hans Wildiers

3 joint publications

Charlotte Grégoire

3 joint publications

Nadia Harbeck

3 joint publications

Concetta Elisa Onesti